Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abbott, AbbVie, absence, absorb, ACE, Acelyrin, ADC, adjuvant, ADPKD, advice, Advisor, advocating, Affymax, Alpine, Alza, Amgen, Amylin, Andra, anemia, Ann, anniversary, Ardea, Arizona, Array, Ascension, Atara, Atreca, aTyr, autoimmune, Avalo, bachelor, backdrop, background, Baltimore, Bar, Barbara, Bayer, Beecham, Bellevue, Berkeley, bifurcation, billion, biochemistry, BioCity, Biocom, Biology, biomarker, BioOncology, BioPharma, Biotech, Black, blood, Boehringer, boxed, breakthrough, Brickell, Brobeck, Bruhn, cadence, cancer, Candel, career, CARGO, Carnegie, Carondelet, Catholic, Celladon, centricity, Cerecor, CFA, Chair, charter, Chattanooga, Chattem, Chicago, Christopher, CKD, Clara, Cline, CoCrystal, college, conditionally, Cornell, Coughlin, CRADA, creditor, Crescent, cum, cycle, deadline, debilitating, deceptive, Deciphera, DePaul, deprioritized, destabilized, diabetic, disappointing, disciplinary, division, DMV, doctorate, dominant, downturn, Dr, Dublin, Duke, EDA, edema, editing, Eikon, elagolix, Elan, Eli, embedded, enterprise, environmental, epidemic, Ernst, ESG, Esprit, Excellence, exploit, exploited, faculty, Falk, faster, Fate, fellow, fellowship, filer, fill, FILSPARI, Fisher, Floor, Fordham, Foundation, Franchise, Fresh, Galenica, Gary, gather, gathering, Genentech, genome, Genzyme, geopolitical, Gilead, GlaxoSmithKline, glucose, Graduate, Hampshire, Harrison, Harvard, harvesting, HCV, Hematology, HengRui, hepatology, hepatotoxicity, holder, Hospira, hybrid, hyperkalemia, hypertension, hypotension, Idorsia, immune, ImmunoGen, Immunology, immunotherapy, impediment, infer, Inflammation, inflammatory, inflationary, Ingelheim, INGREZZA, Inrig, Intec, interventional, invasion, investor, Iowa, IQVIA, IRA, irbesartan, Ireland, Irvine, Janssen, Jardiance, Jiangsu, Johannesburg, Johnson, joined, joining, journey, Jula, Kaiser, Kaneka, Kellogg, Kentucky, KentuckyOne, Kerendia, Kinpeygo, landscape, laude, lawfully, Leadiant, led, liaison, licensor, Lilly, Linda, Liposorber, LLL, LogicBio, Loma, Lund, macroeconomic, Marine, Maryland, Mayne, MBA, Mellon, Memorial, Merck, merged, message, Michigan, military, Mind, MindMed, mineralocorticoid, misrepresentative, mitochondrial, Mount, multibackground, Mythic, Natera, nephrology, Neurocrine, NeurogesX, neuroscience, nominal, nonbifurcation, Nonrefundable, Northwest, Northwestern, notwithstanding, Novelion, obesity, oncology, onset, ophthalmic, Oregon, ORILISSA, orthostatic, outlook, outpace, owner, partnership, pegtarviliase, Peloton, penalize, pension, peripheral, Permanente, PharmaKrysto, philosophy, Phleger, Phoenix, Physiotherapy, plc, Pliant, polycystic, Portland, postdoctoral, postmarketing, predominant, presidential, Proclara, procurement, Professor, Promedior, pursuit, QLT, Raptor, raw, ready, recourse, recurrence, refinancing, regular, Rehabilitation, Relypsa, Reneo, residual, resistant, Respiratory, retail, retaliatory, Rigel, River, Ron, Rorer, Russian, Ruth, SA, Sacramento, Sangstat, Santa, School, Seagen, Shire, SmithKline, sodium, spent, Squarer, Sr, Stenden, streamline, Street, suburban, Supervisory, Suzanne, Sweden, Syncopation, Tarpeyo, Temple, Tennessee, tension, tenure, theoretically, Thermo, Tiaki, Timothy, totalcare, Transkaryotic, Tucson, Ukraine, undermine, unsettled, upper, Upstream, valbenazine, ValenzaBio, Valneva, variation, ViaCyte, Vigil, Viiv, virtual, wake, Washington, Waterloo, Wayne, wholly, wiretapping, withstand, Witwatersrand, Xavier, York, Young
Removed:
accrue, annum, Aselage, bore, cancellation, ceiling, closed, compliant, comport, correlated, creatinine, customary, deployed, Dohmen, dosed, forfeiture, guideline, hub, iga, intentionally, line, mix, modeling, move, netted, Nexgen, Noah, nonconvertible, overcharge, overcharging, partnered, placement, protein, rank, replaced, Rosenberg, ruling, semiannually, settled, simplified, SPA, Stephen, taxation, tied, undergoing
Filing tables
Filing exhibits
Related press release
Associated TVTX transcripts
TVTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Travere Therapeutics, Inc.
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-259311) and Form S-8 (Nos. 333-266957, 333-258257, 333-240222, 333-232857, 333-224848, 333-218582, 333-213599, 333-206510 and 333-200224) of Travere Therapeutics, Inc. (“the Company”) of our reports dated February 23, 2023, relating to the consolidated financial statements, and the effectiveness of the Company’s internal control over financial reporting, which appear in this Form 10-K. Our report on the effectiveness of internal control over financial reporting expresses an adverse opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2022.
/s/ BDO USA, LLP
San Diego, California
February 23, 2023